MeMed is a host response company having developed innovative diagnostic host immune response tests that address complex clinical dilemmas and improve patient outcomes.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |